Mangoceuticals, Common Stock Stock Buy Hold or Sell Recommendation
| MGRX Stock | 2.50 0.03 1.19% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Mangoceuticals, Common Stock is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Mangoceuticals, Common Stock given historical horizon and risk tolerance towards Mangoceuticals, Common. When Macroaxis issues a 'buy' or 'sell' recommendation for Mangoceuticals, Common Stock, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Mangoceuticals, Common Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Mangoceuticals, and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Mangoceuticals, |
Execute Mangoceuticals, Common Buy or Sell Advice
The Mangoceuticals, recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mangoceuticals, Common Stock. Macroaxis does not own or have any residual interests in Mangoceuticals, Common Stock or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mangoceuticals, Common's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Mangoceuticals, Common Trading Alerts and Improvement Suggestions
| Mangoceuticals, Common generated a negative expected return over the last 90 days | |
| Mangoceuticals, Common has high historical volatility and very poor performance | |
| Mangoceuticals, Common has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 731.49 K. Net Loss for the year was (9.21 M) with profit before overhead, payroll, taxes, and interest of 4.85 K. | |
| Mangoceuticals, Common generates negative cash flow from operations | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 |
Mangoceuticals, Common Returns Distribution Density
The distribution of Mangoceuticals, Common's historical returns is an attempt to chart the uncertainty of Mangoceuticals, Common's future price movements. The chart of the probability distribution of Mangoceuticals, Common daily returns describes the distribution of returns around its average expected value. We use Mangoceuticals, Common Stock price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mangoceuticals, Common returns is essential to provide solid investment advice for Mangoceuticals, Common.
| Mean Return | -0.23 | Value At Risk | -7.65 | Potential Upside | 7.29 | Standard Deviation | 5.87 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mangoceuticals, Common historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Mangoceuticals, Common Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mangoceuticals, Common or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mangoceuticals, Common's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mangoceuticals, stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | -0.11 | |
σ | Overall volatility | 5.55 | |
Ir | Information ratio | -0.06 |
Mangoceuticals, Common Volatility Alert
Mangoceuticals, Common Stock exhibits very low volatility with skewness of 1.52 and kurtosis of 5.52. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Mangoceuticals, Common's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Mangoceuticals, Common's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Mangoceuticals, Common Fundamentals Vs Peers
Comparing Mangoceuticals, Common's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mangoceuticals, Common's direct or indirect competition across all of the common fundamentals between Mangoceuticals, Common and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mangoceuticals, Common or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mangoceuticals, Common's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mangoceuticals, Common by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Mangoceuticals, Common to competition |
| Fundamentals | Mangoceuticals, Common | Peer Average |
| Return On Equity | -1.08 | -0.31 |
| Return On Asset | -0.58 | -0.14 |
| Operating Margin | (13.05) % | (5.51) % |
| Current Valuation | 6.49 M | 16.62 B |
| Shares Outstanding | 2.49 M | 571.82 M |
| Shares Owned By Insiders | 37.45 % | 10.09 % |
| Shares Owned By Institutions | 4.69 % | 39.21 % |
| Number Of Shares Shorted | 152.88 K | 4.71 M |
| Price To Book | 0.47 X | 9.51 X |
| Price To Sales | 7.26 X | 11.42 X |
| Revenue | 731.49 K | 9.43 B |
| Gross Profit | 4.85 K | 27.38 B |
| EBITDA | (9.19 M) | 3.9 B |
| Net Income | (9.21 M) | 570.98 M |
| Total Debt | 128.68 K | 5.32 B |
| Book Value Per Share | 0.54 X | 1.93 K |
| Cash Flow From Operations | (7 M) | 971.22 M |
| Short Ratio | 0.21 X | 4.00 X |
| Earnings Per Share | (5.70) X | 3.12 X |
| Number Of Employees | 3 | 18.84 K |
| Market Capitalization | 6.29 M | 19.03 B |
| Total Asset | 1.05 M | 29.47 B |
| Retained Earnings | (11.23 M) | 9.33 B |
| Working Capital | 607.38 K | 1.48 B |
| Net Asset | 1.05 M |
Note: Acquisition by Eugene Johnston of 25000 shares of Mangoceuticals, Common subject to Rule 16b-3 [view details]
Mangoceuticals, Common Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mangoceuticals, . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Mangoceuticals, Common Buy or Sell Advice
When is the right time to buy or sell Mangoceuticals, Common Stock? Buying financial instruments such as Mangoceuticals, Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Mangoceuticals, Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Absolute Returns ETFs Thematic Idea Now
Absolute Returns ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Absolute Returns ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Absolute Returns ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.